Literature DB >> 24067770

Potential risk of artificial cerebrospinal fluid solution without magnesium ion for cerebral irrigation and perfusion in neurosurgical practice.

Kentaro Mori1, Takuji Yamamoto, Masahiro Miyazaki, Yasukazu Hara, Nobuhiro Koike, Yasuaki Nakao.   

Abstract

The effect of irrigation with artificial cerebrospinal fluid (CSF) containing various magnesium ion (Mg(2+)) concentrations on vasospastic arteries was investigated in the dog. Cerebral vasospasm was induced by the experimental subarachnoid hemorrhage model in 15 beagle dogs. Cisternal irrigation was performed for 1 hour via a microcatheter placed in the cisterna magna with commercially available artificial CSF (ARTCEREB®) with physiological concentration of Mg(2+) (2.2 mEq/l) (ACM group, n = 5), ARTCEREB solution without Mg(2+) (ACR group, n = 5), and ARTCEREB solution with higher Mg(2+) concentration (5 mEq/l) (ACMM group, n = 5). CSF electrolyte concentrations and the diameters of the basilar and vertebral arteries were measured. In the ACM group, no changes were detected in either CSF Mg(2+) concentration or arterial diameters. In the ACR group, the CSF Mg(2+) decreased significantly to 0.8 ± 0.07 mEq/l from the baseline value of 1.4 ± 0.03 mEq/l, and both basilar and vertebral artery diameters were significantly decreased to 0.61 ± 0.18 mm and 0.57 ± 0.23 mm from their baseline values of 0.74 ± 0.22 mm and 0.68 ± 0.17 mm, respectively. In the ACMM group, the CSF Mg(2+) significantly increased to 2.4 ± 0.15 mEq/l from the baseline value of 1.4 ± 0.05 mEq/l, and both basilar and vertebral artery diameters were significantly increased to 0.84 ± 0.19 mm and 0.90 ± 0.22 mm from their baseline values of 0.71 ± 0.21 mm and 0.69 ± 0.24 mm, respectively. Irrigation with artificial CSF solution without Mg(2+) causes vasoconstriction of the cerebral artery. Irrigation with artificial CSF with appropriate Mg(2+) concentration is essential, especially in patients with subarachnoid hemorrhage.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24067770      PMCID: PMC4508684          DOI: 10.2176/nmc.oa2012-0295

Source DB:  PubMed          Journal:  Neurol Med Chir (Tokyo)        ISSN: 0470-8105            Impact factor:   1.742


  15 in total

1.  Urokinase cisternal irrigation therapy for prevention of symptomatic vasospasm after aneurysmal subarachnoid hemorrhage: a study of urokinase concentration and the fibrinolytic system.

Authors:  T Sasaki; N Kodama; M Kawakami; M Sato; J Asari; Y Sakurai; K Watanabe; T Onuma; T Matsuda
Journal:  Stroke       Date:  2000-06       Impact factor: 7.914

2.  Imaging mass spectrometry evaluation of the effects of various irrigation fluids in a rat model of postoperative cerebral edema.

Authors:  Shinichiro Koizumi; Takahiro Hayasaka; Naoko Goto-Inoue; Kazuhisa Doi; Mitsutoshi Setou; Hiroki Namba
Journal:  World Neurosurg       Date:  2011-11-17       Impact factor: 2.104

3.  Optimal cerebrospinal fluid magnesium ion concentration for vasodilatory effect and duration after intracisternal injection of magnesium sulfate solution in a canine subarachnoid hemorrhage model.

Authors:  Kentaro Mori; Takuji Yamamoto; Masahiro Miyazaki; Yasukazu Hara; Yasuhisa Aiko; Nobuhiro Koike; Shinsuke Sakamoto; Yasuaki Nakao; Takanori Esaki
Journal:  J Neurosurg       Date:  2010-11-12       Impact factor: 5.115

4.  Vasomotor response induced by change of extracellular potassium and magnesium in cerebral penetrating arterioles.

Authors:  Takahiro Murata; Tetsuyoshi Horiuchi; Tetsuya Goto; Yuhui Li; Kazuhiro Hongo
Journal:  Neurosci Res       Date:  2011-02-01       Impact factor: 3.304

5.  Surgical procedure and results of cisternal washing therapy for the prevention of cerebral vasospasm following SAH.

Authors:  Tadayoshi Nakagomi; Kazuhide Furuya; Hiroshi Nagashima; Jun-Ichi Tanaka; Teruyuki Ishii; Shigehiko Takanashi; Takeyuki Shinohara; Fumihiro Watanabe; Akiko Ogawa; Norio Fujii; Akira Tamura
Journal:  Acta Neurochir Suppl       Date:  2011

6.  Cerebral blood flow after surgery for unruptured cerebral aneurysms: effects of surgical manipulation and irrigation fluid.

Authors:  Hiroaki Shimizu; Takashi Inoue; Miki Fujimura; Atsushi Saito; Teiji Tominaga
Journal:  Neurosurgery       Date:  2011-09       Impact factor: 4.654

7.  Cisternal irrigation therapy with urokinase and ascorbic acid for prevention of vasospasm after aneurysmal subarachnoid hemorrhage. Outcome in 217 patients.

Authors:  N Kodama; T Sasaki; M Kawakami; M Sato; J Asari
Journal:  Surg Neurol       Date:  2000-02

8.  Novel vasodilatory effect of intracisternal injection of magnesium sulfate solution on spastic cerebral arteries in the canine two-hemorrhage model of subarachnoid hemorrhage.

Authors:  Kentaro Mori; Masahiro Miyazaki; Yasukazu Hara; Yasuhisa Aiko; Takuji Yamamoto; Yasuaki Nakao
Journal:  J Neurosurg       Date:  2009-01       Impact factor: 5.115

9.  Perfusion fluids used in neurosurgery affect cerebrospinal fluid and surrounding brain parenchyma in the rat ventriculocisternal perfusion model.

Authors:  Kazuhisa Doi; Yujiro Morioka; Masuhiro Nishimura; Takeshi Kawano; Daisuke Harada; Shinsaku Naito; Aiko Yamauchi
Journal:  J Toxicol Sci       Date:  2009-10       Impact factor: 2.196

10.  Intracisternal infusion of magnesium sulfate solution improved reduced cerebral blood flow induced by experimental subarachnoid hemorrhage in the rat.

Authors:  Kentaro Mori; Masahiro Miyazaki; Junko Iwata; Takuji Yamamoto; Yasuaki Nakao
Journal:  Neurosurg Rev       Date:  2008-02-06       Impact factor: 3.042

View more
  2 in total

1.  Implantable Systems for Continuous Liquorpheresis and CSF Replacement.

Authors:  Manuel Menéndez González
Journal:  Cureus       Date:  2017-02-10

2.  Effects of intravenous infusion of hydrogen-rich fluid combined with intra-cisternal infusion of magnesium sulfate in severe aneurysmal subarachnoid hemorrhage: study protocol for a randomized controlled trial.

Authors:  Satoru Takeuchi; Kentaro Mori; Hirohiko Arimoto; Kazuya Fujii; Kimihiro Nagatani; Satoshi Tomura; Naoki Otani; Hideo Osada; Kojiro Wada
Journal:  BMC Neurol       Date:  2014-09-09       Impact factor: 2.474

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.